METHOD FOR IDENTIFYING CLINICAL TRIAL RESPONDERS FROM A PLACEBO GROUP IN MAJOR DEPRESSION

• 1. 用于确定患有BRAF‑阳性癌症的患者为BRAF抑制剂非响应者且为MAPK/ERK抑制剂响应者的工具和方法 [P] . 中国专利： CN107148481A . 2017-09-08
• 2. 对免疫球蛋白治疗时出现的NK细胞调节作用有反应者和无反应者的测定和评估方法 [P] . 中国专利： CN101910840A . 2010-12-08
• 3. METHOD FOR IDENTIFYING CLINICAL TRIAL RESPONDERS FROM A PLACEBO GROUP IN MAJOR DEPRESSION [P] . 欧洲知识产权局专利： EP3429472A4 . 2019-11-20

  机译： 从主要抑郁症的地方人群中识别临床试验反应者的方法

• 4. METHOD FOR IDENTIFYING CLINICAL TRIAL RESPONDERS FROM A PLACEBO GROUP IN MAJOR DEPRESSION [P] . 美国专利： US2019078161A1 . 2019-03-14

  机译： 从主要抑郁症的地方人群中识别临床试验反应者的方法

• 5. METHOD FOR IDENTIFYING CLINICAL TRIAL RESPONDERS FROM A PLACEBO GROUP IN MAJOR DEPRESSION [P] . CA3017749A1 . 2017-09-21

  机译： 从主要抑郁症的地方人群中识别临床试验反应者的方法

• 1. Fluoxetine for poststroke depression A randomized placebo controlled clinical trial [J] . Yan Kong, Wanli Dong, Chunfeng Liu 中国神经再生研究（英文版） . 2007,第003期
• 2. Famitinib versus placebo in the treatment of refractory metastatic colorectal cancer:a multicenter,randomized,double-blinded,placebo-controlled,phaseⅡclinical trial [J] . Rui-Hua Xu, Chang-Ping Wu, Jin Li, 癌症（英文版） . 2017,第012期
• 3. PAID study design on the role of PKC activation in immune/inflammation-related depression:a randomised placebo-controlled trial protocol [J] . Xiaoyun Guo, Ruizhi Mao, Lvchun Cui, 综合精神医学（英文） . 2021,第002期
• 4. Pretreatment neurophysiological and clinical characteristics of placebo responders in treatment trials for major depression. [J] . Leuchter AF, Morgan M, Cook IA, Psychopharmacology . 2004,第1a2期
• 5. Pretreatment neurophysiological and clinical characteristics of placebo responders in treatment trials for major depression [J] . Andrew F. Leuchter, Melinda Morgan, Ian A. Cook, Psychopharmacology . 2004,第1a2期
• 6. Mirroring everyday clinical practice in clinical trial design: a new concept to improve the external validity of randomized double-blind placebo-controlled trials in the pharmacological treatment of major depression [J] . Emanuel Severus, Florian Seemüller, Michael Berger, BMC Medicine . 2012,第1期
• 7. Measurement Issues of Some Widely Used Instruments May Mask Positive Findings in Medical Research -With Illustration of the Hamilton Rating Scale for Depression (HRSD) in a Large Clinical Trial for Major Depression [C] . Chengwu Yang, Wenle Zhao Second joint biostatistics symposium (2012) . 2012
• 8. Patient motivation for participation in clinical trials for depression: Development and validation of the Motivation for Clinical Trials Inventory -Depression (MCTI-D) [D] . Loraas, Emily L. 2006
• 9. Mirroring everyday clinical practice in clinical trial design: a new concept to improve the external validity of randomized double-blind placebo-controlled trials in the pharmacological treatment of major depression [O] . Emanuel Severus, Florian Seemüller, Michael Berger, 2012
• 10. Mirroring everyday clinical practice in clinical trial design: a new concept to improve the external validity of randomized double-blind placebo-controlled trials in the pharmacological treatment of major depression [O] . Emanuel Severus, Florian Seemüller, Michael Berger, 2012

• 1. Effects of Religious vs. Conventional Cognitive-Behavioral Therapy on Inflammatory Markers and Stress Hormones in Major Depression and Chronic Medical Illness: A Randomized Clinical Trial [J] . Lee S. Berk ,Denise L. Bellinger ,Harold G. Koenig . 精神病学期刊（英文） . 2015,第3期
• 2. Effect of Vitamin E and Alpha Lipoic Acid in Nonalcoholic Fatty Liver Disease: A Randomized, Placebo-Controlled, Open-Label, Prospective Clinical Trial (VAIN Trial) [J] . Patrick P. Basu ,Niraj J. Shah ,Mark M. Aloysius . 肠胃病学期刊（英文） . 2014,第5期
• 3. 中国汉族人群中重度抑郁症与GRM7基因多态性的关联研究 [C] . 牛伟博 ,黄晓叶 ,余涛 . 中国神经科学学会精神病学基础与临床分会第十三届学术年会 . 2016
• 4. 地方民事司法改革研究——主要以地方法院的改革为分析对象 [A] . 胡少波 . 2017